Vivani Medical, Inc. Common Stock (DE)
VANIVivani Medical, Inc. (VANI) is a biotechnology company focused on developing innovative solutions for the treatment of chronic conditions. The firm specializes in advanced drug delivery systems and regenerative medicine technologies aimed at improving patient outcomes and quality of life.
Company News
Vivani Medical is raising approximately $15.7 million through a registered direct offering of 6 million shares and a private placement of 3.7 million shares at $1.62 per share. The proceeds will fund research, clinical development, and general corporate purposes.
Vivani Medical plans to initiate the first clinical study for its NPM-115 program, a 6-month GLP-1 implant for chronic weight management, in Australia in Q4 2024. The study will evaluate the safety, tolerability, and pharmacokinetic profile of the exenatide implant compared to weekly semaglutide injections and Bydureon BCise.
Use these tips to understand fundamentals with penny stocks The post Tips for Understanding Penny Stocks Fundamentals appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
